Maarso 2023: Soo koobid kooban: Ujeedada tijaabadan caafimaad waa in la ogaado haddii anti-MESO antigen reseptor CAR T-cell therapy loo isticmaali karo in lagu daweeyo kansarka ugxan-sidaha epithelial ee soo noqday ama joojiyay ka jawaabista kuwa kale.
16-ka Maarso 2023: Daawaynta kansarka waxaa wax ka beddelaya dawooyin cusub oo difaaca jirka ah oo bar-tilmaameedsada microenvironment-ka goobta burada. Unugyada T ee leh reseptors-kimeric antigen (CAR) ayaa si weyn loo baaray.
JANUARY 27, 2023—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), oo ah shirkad caalami ah oo cilmiga bayoolajiga ah oo horumarinaysa, soo saari doonta, kana ganacsanaysa daawayn cusub oo lagu daweynayo cudurrada nafta halis gelinaya, ayaa maanta lagu dhawaaqay in ..
SHANGHAI, Shiinaha, Feebarwari 28, 2023 - JW Therapeutics (HKEX: 2126), oo ah shirkad madax-bannaan oo tignoolajiyada casriga ah ee diiradda saaraysa horumarinta, soo saarista iyo ka-ganacsiga alaabada tallaalka unugyada, ayaa ku dhawaaqday bilawga ...
Maarso 2022: Daaweynta CAR-T, Tignoolajiyada CAR-T, waa maxay CAR-T immunotherapy? Qiimaha daawaynta CAR-T, qiimaha, koobitaanka macluumaadka qoritaanka tijaabada caafimaad ee ugu dambeeyay ee CAR-T. Fikradda boron neutron qabashada therapy waxay ahayd ..
Cilmi-baarayaasha Mayo Clinic ee xarunta Mayo Clinic Florida waxay heleen deeq federaal ah oo shan sano ah oo dhan $ 13 milyan si loogu tijaabiyo tallaalada loogu talagalay si looga hortago soo noqoshada kansarka naasaha ee saddex-laaban. Kansarka naasaha ee saddex-geesoodka ah